These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 16533497

  • 21. Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat.
    Tzschentke TM, Rutten K.
    Neuropharmacology; 2018 Feb; 129():100-108. PubMed ID: 29155273
    [Abstract] [Full Text] [Related]

  • 22. Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats.
    Ciccocioppo R, Economidou D, Fedeli A, Angeletti S, Weiss F, Heilig M, Massi M.
    Psychopharmacology (Berl); 2004 Mar; 172(2):170-8. PubMed ID: 14624331
    [Abstract] [Full Text] [Related]

  • 23. NOP receptor antagonism reduces alcohol drinking in male and female rats through mechanisms involving the central amygdala and ventral tegmental area.
    Borruto AM, Fotio Y, Stopponi S, Brunori G, Petrella M, Caputi FF, Romualdi P, Candeletti S, Narendran R, Rorick-Kehn LM, Ubaldi M, Weiss F, Ciccocioppo R.
    Br J Pharmacol; 2020 Apr; 177(7):1525-1537. PubMed ID: 31713848
    [Abstract] [Full Text] [Related]

  • 24. The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking.
    Kuzmin A, Kreek MJ, Bakalkin G, Liljequist S.
    Neuropsychopharmacology; 2007 Apr; 32(4):902-10. PubMed ID: 16880770
    [Abstract] [Full Text] [Related]

  • 25. Pharmacological characterization of the nociceptin/orphanin FQ receptor on ethanol-mediated motivational effects in infant and adolescent rats.
    Miranda-Morales RS, Pautassi RM.
    Behav Brain Res; 2016 Feb 01; 298(Pt A):88-96. PubMed ID: 25907741
    [Abstract] [Full Text] [Related]

  • 26. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D.
    Br J Pharmacol; 2002 May 01; 136(2):303-11. PubMed ID: 12010780
    [Abstract] [Full Text] [Related]

  • 27. Rostromedial tegmental nucleus nociceptin/orphanin FQ (N/OFQ) signaling regulates anxiety- and depression-like behaviors in alcohol withdrawn rats.
    Li W, Ren Z, Tang Y, Fu Y, Sun S, Ding R, Hou J, Mai Y, Zhan B, Zhu Y, Zuo W, Ye JH, Fu R.
    Neuropsychopharmacology; 2023 May 01; 48(6):908-919. PubMed ID: 36329156
    [Abstract] [Full Text] [Related]

  • 28. Swim stress enhances nociceptin/orphanin FQ-induced inhibition of rat dorsal raphe nucleus activity in vivo and in vitro: role of corticotropin releasing factor.
    Nazzaro C, Barbieri M, Varani K, Beani L, Valentino RJ, Siniscalchi A.
    Neuropharmacology; 2010 Feb 01; 58(2):457-64. PubMed ID: 19747494
    [Abstract] [Full Text] [Related]

  • 29. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD, Harbuz MS, Jessop DS, Fulford AJ.
    Neuroscience; 2006 Sep 15; 141(4):2051-7. PubMed ID: 16784820
    [Abstract] [Full Text] [Related]

  • 30. The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models.
    Aziz AM, Brothers S, Sartor G, Holm L, Heilig M, Wahlestedt C, Thorsell A.
    Psychopharmacology (Berl); 2016 Oct 15; 233(19-20):3553-63. PubMed ID: 27515665
    [Abstract] [Full Text] [Related]

  • 31. Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy.
    Eschenroeder AC, Vestal-Laborde AA, Sanchez ES, Robinson SE, Sato-Bigbee C.
    Glia; 2012 Jan 15; 60(1):125-36. PubMed ID: 22002899
    [Abstract] [Full Text] [Related]

  • 32. Effect of nociceptin on alcohol intake in alcohol-preferring rats.
    Ciccocioppo R, Panocka I, Polidori C, Regoli D, Massi M.
    Psychopharmacology (Berl); 1999 Jan 15; 141(2):220-4. PubMed ID: 9952048
    [Abstract] [Full Text] [Related]

  • 33. Hypericum perforatum CO2 extract and opioid receptor antagonists act synergistically to reduce ethanol intake in alcohol-preferring rats.
    Perfumi M, Santoni M, Cippitelli A, Ciccocioppo R, Froldi R, Massi M.
    Alcohol Clin Exp Res; 2003 Oct 15; 27(10):1554-62. PubMed ID: 14574225
    [Abstract] [Full Text] [Related]

  • 34. Involvement of the Nociceptin/Orphanin FQ-NOP receptor system in the ventrolateral periaqueductal gray following mechanical allodynia in chronic pain.
    Scoto GM, Aricò G, Iemolo A, Ronsisvalle S, Parenti C.
    Life Sci; 2009 Jul 31; 85(5-6):206-10. PubMed ID: 19523963
    [Abstract] [Full Text] [Related]

  • 35. The gastric effects of UFP-112, a new nociceptin/orphanin receptor agonist, in physiological and pathological conditions.
    Broccardo M, Guerrini R, Morini G, Polidori C, Agostini S, Petrella C, Improta G.
    Peptides; 2007 Oct 31; 28(10):1974-81. PubMed ID: 17765363
    [Abstract] [Full Text] [Related]

  • 36. The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo.
    Brookes ZL, Stedman EN, Brown NJ, Hebbes CP, Guerrini R, Calo G, Reilly CS, Lambert DG.
    PLoS One; 2013 Oct 31; 8(9):e74943. PubMed ID: 24086402
    [Abstract] [Full Text] [Related]

  • 37. Antihyperalgesic effect of buprenorphine involves nociceptin/orphanin FQ peptide-receptor activation in rats with spinal nerve injury-induced neuropathy.
    Takahashi T, Okubo K, Kojima S, Nishikawa H, Takemura M, Tsubota-Matsunami M, Sekiguchi F, Kawabata A.
    J Pharmacol Sci; 2013 Oct 31; 122(1):51-4. PubMed ID: 23603932
    [Abstract] [Full Text] [Related]

  • 38. Exploring LPS-induced sepsis in rats and mice as a model to study potential protective effects of the nociceptin/orphanin FQ system.
    Thomas RC, Bath MF, Stover CM, Lambert DG, Thompson JP.
    Peptides; 2014 Nov 31; 61():56-60. PubMed ID: 25161013
    [Abstract] [Full Text] [Related]

  • 39. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
    Zhang Y, Simpson-Durand CD, Standifer KM.
    Br J Pharmacol; 2015 Jan 31; 172(2):571-82. PubMed ID: 24666365
    [Abstract] [Full Text] [Related]

  • 40. MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforcement in post-dependent rats.
    de Guglielmo G, Martin-Fardon R, Teshima K, Ciccocioppo R, Weiss F.
    Addict Biol; 2015 Jul 31; 20(4):643-51. PubMed ID: 24930632
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.